124 related articles for article (PubMed ID: 29345284)
1. Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.
Li L; Yang D; Cui D; Li Y; Nie Z; Wang J; Liang L
Int J Oncol; 2018 Feb; 52(2):473-484. PubMed ID: 29345284
[TBL] [Abstract][Full Text] [Related]
2. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
Yang W; Wu B; Ma N; Wang Y; Guo J; Zhu J; Zhao S
In Vitro Cell Dev Biol Anim; 2019 Jun; 55(6):445-452. PubMed ID: 31140101
[TBL] [Abstract][Full Text] [Related]
3. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
5. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
6. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
Yang YX; Hu HD; Zhang DZ; Ren H
J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
8. Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell.
Zhang YH; Wu Q; Xiao XY; Li DW; Wang XP
Cancer Lett; 2010 May; 291(1):76-82. PubMed ID: 19883972
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells.
Hu HD; Ye F; Zhang DZ; Hu P; Ren H; Li SL
J Biomed Biotechnol; 2010; 2010():571343. PubMed ID: 20625496
[TBL] [Abstract][Full Text] [Related]
10. A Positive Tetraspanin 8 (TSPAN8)/β-Catenin Regulatory Loop Enhances the Stemness of Colorectal Cancer Cells.
Zhan Z; Zhong L; Feng M; Guo Y
Med Sci Monit; 2019 Dec; 25():9594-9601. PubMed ID: 31838484
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
Zhang X; Bo P; Liu L; Zhang X; Li J
Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.
Tan B; Li Y; Zhao Q; Fan L; Liu Y; Wang D; Zhao X
Cancer Gene Ther; 2014 Dec; 21(12):526-31. PubMed ID: 25430880
[TBL] [Abstract][Full Text] [Related]
13. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
[TBL] [Abstract][Full Text] [Related]
14. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
15. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
17. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line.
Yang YX; Chen ZC; Zhang GY; Yi H; Xiao ZQ
J Cell Biochem; 2008 Jun; 104(3):1010-21. PubMed ID: 18253933
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
20. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]